PLUS1
6.00
0.30 (5.26%)
0.30 (5.26%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aridis Pharmaceuticals Inc | ARDS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 5.70 | 5.15 | 5.90 | 5.50 | 5.70 | 16:50:10 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.18 | 5.99 | 1.81 | 30.22% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 26 | 1,599 | $ 5.65 | $ 9,034 | 5,868 | 3.80 - 12.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:10:12 | 1 | $ 6.00 | USD |
Aridis Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 50.80M | 8.91M | $ -22.11M | 1.99 | 2.20 | 7.47M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 1.00 | 16.20% |
Aridis Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/30/2020 | 16:16 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt.. |
| 3/06/2020 | 17:19 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 3/06/2020 | 16:05 | PR Newswire (US) | Aridis Pharmaceuticals to Postpone Investor Day Due to.. |
| 3/05/2020 | 08:51 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 3/05/2020 | 05:30 | PR Newswire (US) | Aridis Pharmaceuticals to Present at the 32nd Annual ROTH.. |
| 3/04/2020 | 16:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 3/04/2020 | 05:30 | PR Newswire (US) | Aridis Pharmaceuticals Provides Update on Investor Day.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARDS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.62 | 6.25 | 5.15 | 5.60 | 1,425 | 0.08 | 1.42% |
| 1 Month | 5.86 | 7.40 | 3.80 | 5.09 | 6,665 | -0.16 | -2.73% |
| 3 Months | 7.30 | 9.00 | 3.80 | 6.58 | 9,784 | -1.60 | -21.92% |
| 6 Months | 6.78 | 9.00 | 3.80 | 5.78 | 12,512 | -1.08 | -15.93% |
| 1 Year | 10.53 | 12.40 | 3.80 | 7.16 | 9,633 | -4.83 | -45.87% |
| 3 Years | 13.02 | 13.85 | 3.80 | 9.24 | 10,365 | -7.32 | -56.22% |
| 5 Years | 13.02 | 13.85 | 3.80 | 9.24 | 10,365 | -7.32 | -56.22% |
Aridis Pharmaceuticals Description
| Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. |
